VISCO VISION INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 270 TWD | +0.75% |
|
-1.64% | +24.42% |
| Sales 2024 * | 342.15Cr 11Cr 880.29Cr | Sales 2025 * | 409.41Cr 13Cr 1.05TCr | Capitalization | 1.81TCr 56Cr 4.65TCr |
|---|---|---|---|---|---|
| Net income 2024 * | 72Cr 2.24Cr 186.53Cr | Net income 2025 * | 85Cr 2.63Cr 218.69Cr | EV / Sales 2024 * | 5.22 x |
| Net cash position 2024 * | 22Cr 67.65L 56Cr | Net cash position 2025 * | 43Cr 1.32Cr 109.86Cr | EV / Sales 2025 * | 4.31 x |
| P/E ratio 2024 * |
23.5
x | P/E ratio 2025 * |
20
x | Employees | - |
| Yield 2024 * |
2.22% | Yield 2025 * |
2.41% | Free-Float | 63.89% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.75% | ||
| 1 week | -1.64% | ||
| Current month | +5.88% | ||
| 1 month | +16.13% | ||
| 3 months | +6.30% | ||
| 6 months | +51.69% | ||
| Current year | +24.42% |
1 week
262.00
282.50
1 month
228.50289.00
Current year
213.00289.00
1 year
154.00289.00
3 years
113.50388.50
5 years
95.00388.50
10 years
95.00388.50
| Managers | Title | Age | Since |
|---|---|---|---|
Chung Yi Li
CEO | Chief Executive Officer | - | 01/13/01 |
Pei Ching Cheng
DFI | Director of Finance/CFO | - | 01/14/01 |
Kun Hui Chen
CTO | Chief Tech/Sci/R&D Officer | - | 01/11/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ko Yung Yu
BRD | Director/Board Member | 68 | 27/14/27 |
Chiu Jui Wei
BRD | Director/Board Member | - | 30/20/30 |
Oliver Liu
BRD | Director/Board Member | - | 27/14/27 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 4 M€ | -4.41% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/24/17 | 270 | +0.75% | 748,326 |
| 14/24/14 | 268 | -2.55% | 1,025,564 |
| 13/24/13 | 275 | -1.61% | 639,265 |
| 12/24/12 | 279.5 | +0.36% | 470,359 |
End-of-day quote Taiwan S.E., June 17, 2024
More quotes
Visco Vision Inc is a Taiwan-based company mainly engaged in the production, design and sale of disposable contact lenses. The Company is engaged in the design and production of a variety of disposable contact lenses with the same water content and oxygen permeability, which can be divided into daily, weekly, bi-weekly and monthly based on the same life cycle. According to the lens function, the products can be divided into general myopia correction, astigmatism, multifocal, anti-blue light lenses, and makeup lenses that can change the color of the iris. The Company distributes its products in Taiwan, Europe, Asia, America and other places.
Calendar
08/08/2024
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
270
TWD
Average target price
314.6
TWD
Spread / Average Target
+16.52%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +24.42% | 53Cr | |
| +13.88% | 10TCr | |
| +19.50% | 4.36TCr | |
| -23.16% | 214.51Cr | |
| +10.78% | 184.12Cr | |
| +19.80% | 114.39Cr | |
| +71.67% | 66Cr | |
| -10.11% | 65Cr | |
| -45.41% | 63Cr | |
| -45.13% | 61Cr |
- Stock Market
- Equities
- 6782 Stock
